Literature DB >> 6337704

Sequence of centromere separation: occurrence, possible significance, and control.

B K Vig.   

Abstract

This review describes the existence of a phenomenon, sequential separation of centromeres, in mitotic cells of various species including both animals and plants. Critical observations at metaanaphase show that the centromeres of chromosomes in a given genome do not separate into two sister units randomly, but that there is a genetically controlled, nonrandom, species-specific sequence which is independent of the length of the chromosome or the position of the centromere. A stricter control appears to exist for late-separating than for early-separating chromosomes. At early stages of metaanaphase several chromosomes initiate onset of separation simultaneously or in rapid succession, but late-separating chromosomes are better defined in their sequential position. The effect of Colcemid on the sequence of separation is minimal. It is proposed that aneuploidy in humans and other organisms may result from out-of-phase separation of a given chromosome. With the exception of chromosome No. 16, it appears that very early- or very late-separating centromeres are involved in human trisomies more often than those in between. Perhaps one function of centromeric heterochromatin is the control of centromere separation. The amount of such chromatin shows a positive correlation with the timing of separation of the centromeres. Superimposed upon this quantitative influence is the qualitative aspect, as discussed for various genomes. This suggestion explains a lack of extremely large quantities of heterochromatin near the centromere. Its existence in the form of homogeneously staining regions distal to the centromere, as in some cancer cells or in sex chromosomes, seemingly has no influence on the separation of centromeres. A brief discussion of centromere separation errors in human disease is provided, and suggestions for further studies are made.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6337704     DOI: 10.1016/0165-4608(83)90142-5

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  15 in total

1.  Premature centromere division of a translocation-carrier autosome.

Authors:  K Méhes; G Kosztolányi
Journal:  Hum Genet       Date:  1990-08       Impact factor: 4.132

2.  Objective analysis of centromere separation.

Authors:  G Mèhes; A Tàrnok; L Pajor; K Mèhes
Journal:  Hum Genet       Date:  1996-03       Impact factor: 4.132

3.  Sequence of centromere separation: separation in a quasi-stable mouse-human somatic cell hybrid.

Authors:  B K Vig; R S Athwal
Journal:  Chromosoma       Date:  1989-09       Impact factor: 4.316

4.  Parental centromere separation sequence and aneuploidy in the offspring.

Authors:  K Bajnóczky; K Méhes
Journal:  Hum Genet       Date:  1988-03       Impact factor: 4.132

5.  Premature centromere division (PCD): a dominantly inherited cytogenetic anomaly.

Authors:  K Madan; D Lindhout; A Palan
Journal:  Hum Genet       Date:  1987-10       Impact factor: 4.132

6.  Sequence of centromere separation: differential replication of pericentric heterochromatin in multicentric chromosomes.

Authors:  B K Vig; D Broccoli
Journal:  Chromosoma       Date:  1988       Impact factor: 4.316

7.  Heterochromatin associated with active versus inactive centromeres of mouse replicates at different times.

Authors:  B K Vig
Journal:  Experientia       Date:  1988-01-15

8.  Significance of structural chromosome aberrations in human sperm: analysis of induced aberrations.

Authors:  A Genescà; J Benet; M R Caballín; R Miró; J R Germà; J Egozcue
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

9.  Sequence of centromere separation another mechanism for the origin of nondisjunction.

Authors:  B K Vig
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

10.  On the mode of evolution of alpha satellite DNA in human populations.

Authors:  B Marçais; J P Charlieu; B Allain; E Brun; M Bellis; G Roizès
Journal:  J Mol Evol       Date:  1991-07       Impact factor: 2.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.